Azelis Group NV (AZE) - Net Assets

Latest as of December 2025: €2.72 Billion EUR ≈ $3.17 Billion USD

Based on the latest financial reports, Azelis Group NV (AZE) has net assets worth €2.72 Billion EUR (≈ $3.17 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€5.41 Billion ≈ $6.32 Billion USD) and total liabilities (€2.69 Billion ≈ $3.15 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Azelis Group NV (AZE) total assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€2.72 Billion
% of Total Assets	50.23%
Annual Growth Rate	12.64%
5-Year Change	20.63%
10-Year Change	N/A
Growth Volatility	28.9

Azelis Group NV - Net Assets Trend (2018–2025)

This chart illustrates how Azelis Group NV's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see market cap of Azelis Group NV.

Annual Net Assets for Azelis Group NV (2018–2025)

The table below shows the annual net assets of Azelis Group NV from 2018 to 2025. Explore AZE operating cash flow to assess how effectively this company generates cash.

Year	Net Assets	Change
2025-12-31	€2.72 Billion ≈ $3.17 Billion	-7.00%
2024-12-31	€2.92 Billion ≈ $3.41 Billion	+9.10%
2023-12-31	€2.68 Billion ≈ $3.13 Billion	+9.71%
2022-12-31	€2.44 Billion ≈ $2.85 Billion	+8.37%
2021-12-31	€2.25 Billion ≈ $2.63 Billion	+84.85%
2020-12-31	€1.22 Billion ≈ $1.42 Billion	-1.35%
2019-12-31	€1.23 Billion ≈ $1.44 Billion	+4.60%
2018-12-31	€1.18 Billion ≈ $1.38 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to Azelis Group NV's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 101130200000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	€989.80 Million	36.73%
Common Stock	€5.88 Billion	218.22%
Total Equity	€2.69 Billion	100.00%

Azelis Group NV Competitors by Market Cap

The table below lists competitors of Azelis Group NV ranked by their market capitalization.

Company	Market Cap
Hanesbrands Inc NYSE:HBI	$2.29 Billion
Société BIC SA PA:BB	$2.29 Billion
Compagnie Financiere Tradition SW:CFT	$2.29 Billion
Beijing Cisri Gaona Materials Tech SHE:300034	$2.29 Billion
Ecopro Co. Ltd KQ:086520	$2.29 Billion
SK Bioscience Co Ltd KO:302440	$2.29 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	$2.29 Billion
Guangdong Advertising Co Ltd SHE:002400	$2.29 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Azelis Group NV's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 2,876,138,000 to 2,694,576,000, a change of -181,562,000 (-6.3%).
Net income of 111,193,000 contributed positively to equity growth.
Dividend payments of 54,906,000 reduced retained earnings.
Share repurchases of 1,138,000 reduced equity.
Other comprehensive income increased equity by 3,880,188,000.
Other factors decreased equity by 4,116,899,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€111.19 Million	+4.13%
Dividends Paid	€54.91 Million	-2.04%
Share Repurchases	€1.14 Million	-0.04%
Other Comprehensive Income	€3.88 Billion	+144.0%
Other Changes	€-4.12 Billion	-152.78%
Total Change	€-	-6.31%

Book Value vs Market Value Analysis

This analysis compares Azelis Group NV's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.01x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 2.24x to 1.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2018-12-31	€5.04	€11.28	x
2019-12-31	€5.28	€11.28	x
2020-12-31	€5.20	€11.28	x
2021-12-31	€9.53	€11.28	x
2022-12-31	€10.20	€11.28	x
2023-12-31	€10.79	€11.28	x
2024-12-31	€11.80	€11.28	x
2025-12-31	€11.15	€11.28	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Azelis Group NV utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 4.13%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.70%
• Asset Turnover: 0.76x
• Equity Multiplier: 2.01x
Recent ROE (4.13%) is below the historical average (4.64%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2018	-1.82%	-8.37%	0.10x	2.23x	€-139.45 Million
2019	3.89%	2.29%	0.73x	2.33x	€-75.41 Million
2020	5.84%	3.03%	0.79x	2.43x	€-50.62 Million
2021	3.04%	2.40%	0.71x	1.79x	€-155.00 Million
2022	8.94%	5.17%	0.83x	2.09x	€-25.26 Million
2023	6.86%	4.28%	0.75x	2.15x	€-81.30 Million
2024	6.28%	4.26%	0.74x	2.00x	€-106.92 Million
2025	4.13%	2.70%	0.76x	2.01x	€-158.26 Million

Industry Comparison

This section compares Azelis Group NV's net assets metrics with peer companies in the Specialty Chemicals industry.

No peer company data available for comparison.

About Azelis Group NV

BR:AZE Belgium Specialty Chemicals

Market Cap

$3.21 Billion

€2.75 Billion EUR

Market Cap Rank

#5781 Global

#30 in Belgium

Share Price

€11.28

Change (1 day)

+1.90%

52-Week Range

€6.95 - €15.24

All Time High

€27.60